Compare FONR & IGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FONR | IGI |
|---|---|---|
| Founded | 1978 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.3M | 96.4M |
| IPO Year | 1995 | 2009 |
| Metric | FONR | IGI |
|---|---|---|
| Price | $18.90 | $15.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 41.2K | 15.4K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $104,351,318.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $16.28 | ★ N/A |
| Revenue Growth | ★ 1.43 | N/A |
| 52 Week Low | $12.14 | $15.78 |
| 52 Week High | $18.88 | $17.09 |
| Indicator | FONR | IGI |
|---|---|---|
| Relative Strength Index (RSI) | 81.21 | 35.99 |
| Support Level | $18.31 | $15.78 |
| Resistance Level | N/A | $16.59 |
| Average True Range (ATR) | 0.05 | 0.15 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 100.00 | 10.07 |
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
Western Asset Invstm Grd Dfnd Opp Tr Inc operates as a non-diversified closed-end management investment company. Its primary investment objective is to provide current income and then liquidate & distribute substantially all of the Fund's net assets to stockholders. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing at least 80% of its net assets in investment-grade corporate fixed-income securities of varying maturities.